Collegium Pharmaceutical, Inc. (COLL) Gross margin 2016–2025
Collegium Pharmaceutical, Inc. (COLL) gross margin by fiscal year — reported gross profit divided by reported revenue.
59.3%FY2025 · since FY2016: 87.6% → 59.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 59.3% | -0.4 pp |
| FY2024 | 59.8% | +2.2 pp |
| FY2023 | 57.5% | +12.4 pp |
| FY2022 | 45.2% | -9.2 pp |
| FY2021 | 54.4% | -3.6 pp |
| FY2020 | 58.0% | +23.3 pp |
| FY2019 | 34.7% | -6.2 pp |
| FY2018 | 40.9% | -50.0 pp |
| FY2017 | 90.9% | +3.3 pp |
| FY2016 | 87.6% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice